Plasma antithrombin activity as a diagnostic and prognostic indicator in dogs: A retrospective study of 149 dogs

Keyphrases

• Antithrombin Activity 100%
• Mortality Risk 100%
• Diagnostic Indicator 100%
• Autoimmune Hemolytic Anemia 100%
• Prognostic Indicator 100%
• Neoplasia 100%
• Clinical Significance 50%
• Odds Ratio 50%
• Thrombosis 50%
• Limited Value 50%
• Hemostatic Abnormalities 50%
• Hyperbilirubinemia 50%
• Disease Course 50%
• Hepatopathy 50%
• Increased Mortality 50%
• High Risk 50%
• Discriminating Factor 50%
• Hypercoagulability 50%
• Activity Measurement 50%
• Receiver Operating Characteristic Analysis 50%
• Veterinary Study 50%
• Leukocytosis 50%
• Optimal Cutoff 50%
• Hypoalbuminemia 50%
• Coagulation 50%
• Prognostic Marker 50%
• Area under the Curve 50%
• Human Medicine 50%
• Mortality Prediction 50%
• Clinicopathologic Findings 50%
• Antithrombin 50%
• Pancreatitis 50%
• Poor Prognosis 50%
• Prognostic Significance 50%
• Human Patients 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Retrospective Study 100%
• Antithrombin 100%
• Neoplasm 66%
• Hemolytic Anemia 66%
• Disease 66%
• Hemostatic Agent 33%
• Leukocytosis 33%
• Hypoalbuminemia 33%
• Pancreatitis 33%
• Thrombosis 33%
• Disease Course 33%
• Hyperbilirubinemia 33%
• Liver Disease 33%
• Hypercoagulability 33%
• Population Study 33%

Veterinary Science and Veterinary Medicine

• Dog 100%
• Blood Plasma 100%
• Pancreatitis 11%
• Hypoalbuminemia 11%